These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4210457)

  • 1. Clozapine--a new antipsychotic agent.
    Simpson GM; Varga E
    Curr Ther Res Clin Exp; 1974 Jul; 16(7):679-86. PubMed ID: 4210457
    [No Abstract]   [Full Text] [Related]  

  • 2. Clozapine--a potential antipsychotic agent without extrapyramidal manifestations.
    Matz R; Rick W; Thompson H; Gershon S
    Curr Ther Res Clin Exp; 1974 Jul; 16(7):687-95. PubMed ID: 4210458
    [No Abstract]   [Full Text] [Related]  

  • 3. Clozapine--a potential antipsychotic agent without extrapyramidal manifestations.
    Matz R; Rick W; Oh D; Thompson H; Gershon S
    Psychopharmacol Bull; 1975 Jan; 11(1):14. PubMed ID: 1121559
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of loxapine succinate in chronic schizophrenia.
    Clark ML; Huber WK; Sullivan J; Wood F; Costiloe JP
    Dis Nerv Syst; 1972 Dec; 33(12):783-91. PubMed ID: 4589978
    [No Abstract]   [Full Text] [Related]  

  • 5. Penfluridol: a long-acting oral neuroleptic as therapeutic agent in chronic schizophrenia.
    Jus A; Pineau R; Jus K; Villeneuve A; Gautier J; Pires P; Drolet A; Cote M; Villeneuve R
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1041-58. PubMed ID: 4215617
    [No Abstract]   [Full Text] [Related]  

  • 6. Clozapine: a new and unusual antipsychotic agent.
    Simpson GM; Varga E
    Psychopharmacol Bull; 1975 Jan; 11(1):14-5. PubMed ID: 235770
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
    Neu C; Dimascio A; Demirgian E
    Curr Ther Res Clin Exp; 1972 May; 14(5):246-51. PubMed ID: 4623975
    [No Abstract]   [Full Text] [Related]  

  • 8. A double-blind comparison of pimozide with carpipramine in schizophrenic patients.
    Kudo Y
    Acta Psychiatr Belg; 1972 Nov; 72(6):685-97. PubMed ID: 4606115
    [No Abstract]   [Full Text] [Related]  

  • 9. [Extrapyramidal symptoms following Clozapine therapy. Case report].
    Doepp S; Buddeberg C
    Nervenarzt; 1975 Oct; 46(10):589-90. PubMed ID: 811999
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of therapeutic effect of clozapin and chlorpromazin (author's transl)].
    Vencovský E; Peterová E; Baudis P
    Cesk Psychiatr; 1975 Jan; 71(1):21-6. PubMed ID: 1093729
    [No Abstract]   [Full Text] [Related]  

  • 11. The comparative anxiolytic effects of placebo, imipramine and chlorimipramine using psychiatric and psychophysiological measurements.
    Lapierre YD
    Int J Clin Pharmacol; 1974 Jan; 9(1):16-22. PubMed ID: 4593126
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of two antipsychotic drugs: chlorpromazine and clozapine (author's transl)].
    Dick P; Rémy M; Rey-Bellet JJ
    Ther Umsch; 1975 Aug; 32(8):497-500. PubMed ID: 1099714
    [No Abstract]   [Full Text] [Related]  

  • 13. A double-blind evaluation of metiapine in hospitalized acute schizophrenics.
    Kramer M; Roth T; Goldstein S; Ryan MS; Blackwell B
    Curr Ther Res Clin Exp; 1975 Dec; 18(6):839-48. PubMed ID: 2450
    [No Abstract]   [Full Text] [Related]  

  • 14. Loxapine succinate: a controlled double-blind study in schizophrenia.
    Charalampous KD; Freemesser GF; Malev J; Ford K
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):829-37. PubMed ID: 4217251
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of neuroleptic withdrawal on the drug-induced extrapyramidal syndrome of chronic schizophrenia].
    Elie R; Gagnon MA; Gauthier R; Jéquier JC
    Union Med Can; 1975 Jun; 104(6):909-14. PubMed ID: 772906
    [No Abstract]   [Full Text] [Related]  

  • 16. Potentiation of haloperidol by -methyldopa in the treatment of schizophrenic patients.
    Chouinard G; Serrano PM; Tetreault L
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):473-83. PubMed ID: 4198310
    [No Abstract]   [Full Text] [Related]  

  • 17. [Influence of clozapine on neuroleptigenic extrapyramidal motor disturbances (author's transl)].
    Zander KJ; Rüther E
    Arzneimittelforschung; 1978; 28(9):1495-6. PubMed ID: 38808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An early clinical trial of lenperone (AHR 2277), a butyrophenone, in chronic schizophrenia.
    Simpson GM; Varga V
    Curr Ther Res Clin Exp; 1974 May; 16(5):477-82. PubMed ID: 4209063
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clozapine--a new antipsychotic agent used in treatment resistance. A good effect but a great risk of adverse effects].
    Wilholm BE; Myrhed M
    Lakartidningen; 1989 Jul; 86(28-29):2508-9. PubMed ID: 2674566
    [No Abstract]   [Full Text] [Related]  

  • 20. A PRELIMINARY STUDY OF P-5227, a new active tricyclic antipsychotic agent.
    Simpson GM; Iqbal J; Iqbal F; Angus JW
    Curr Ther Res Clin Exp; 1966 Oct; 8(10):465-71. PubMed ID: 4961022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.